Provectus Receives Orphan Drug Designation From FDA For The Treatment Of Liver Cancer
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has received orphan drug designation by the U.S. Food and Drug Administration ("FDA") for Rose Bengal, the active ingredient in its novel oncology drug PV-10, for the treatment of hepatocellular carcinoma ("HCC"), the most common form of primary liver cancer. Provectus completed patient ...

FDA Requests Seizure Of Adulterated Breaded Seafood At Wisconsin Firms
Yesterday, at the request of the U.S. Food and Drug Administration, U.S. Marshals seized breaded seafood products that have been repacked by Fellerson, Inc., a firm that does business as K&S Wholesale Meats, for Soderholm Wholesale Foods, both of Sun Prairie, Wis., because the products are adulterated...